Digital Dentistry Growth Might Change The Case For Investing In Align Technology (ALGN)

What Is Align Technology's Investment Narrative?

To own Align Technology, you need to believe that integrated digital dentistry keeps gaining traction and that dentists and orthodontists continue to value a tightly linked system that runs from iTero scans to exocad software to Invisalign treatment. The recent U.S. market reports support that broad premise by highlighting growing digital workflows and clear aligner use, which sit directly in Align Technology's wheelhouse. In the short term, the key levers remain scanner placements, Invisalign case volumes, pricing discipline against lower cost and open systems, and how quickly practices commit to full digital setups rather than cherry picking individual tools.

Execution has to do a lot of heavy lifting. Earnings are forecast to grow 16.01% a year and analysts see scope for the share price to move higher, yet recent performance shows pressure, with the stock down 7.4% year to date and about 19% over 90 days. That mix of improving demand signals and weaker recent returns puts the focus firmly on consistency of case volumes, the impact of large one off items on reported profit, and whether Align Technology can turn its integrated ecosystem into better returns on equity than the current 9.8% over time.

Even so, there is a less comfortable angle to this story that often only becomes obvious when you look at...

There's only one way to know the right time to buy, sell or hold Align Technology. Head to Simply Wall St's company report for the latest analysis of Align Technology's Fair Value.

One alternate view on Align Technology leans heavily into scanner and Systems and Services risk. The most cautious analysts were only modeling about 3.8% annual revenue growth and earnings of roughly US$717.2 million by 2029. That is far below the top estimates. These pre-news forecasts may shift as you reassess the story.

Explore 5 other Align Technology fair value estimates, including one that suggests it could be worth just $154.62.

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

Looking For More Ideas Beyond Align Technology?

If Align Technology has sharpened your interest in digital dentistry and broader healthcare themes, it can be useful to scan a wider field of candidates that fit different risk and income profiles. The Simply Wall St Screener makes that easier by filtering for financial quality, balance sheet strength, and income potential so you can build a watchlist that matches your own style.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Intuit is so interesting through the data lens. It's still near the lows unlike Salesforce which has rebounded.

Salesforce is the classic case of a company written off every cycle and still standing. And Benioff doesn’t give up. He invented the cloud software model, survived the shift he started, bought his way into data, and is now rebuilding the whole thing around agents.

Provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.

Flawless balance sheet and undervalued.